Apixaban 5 mg/1 (Apixaban TABLET, FILM COATED) 5 mg/1

Apixaban 5 mg is an oral anticoagulant used to prevent blood clots. Learn about its uses, effects, and precautions in this comprehensive guide.

Strength

5 mg/1

Pack Size

500 TABLET, FILM COATED in 1 BOTTLE (14445-150-05)

Manufacturer / TM Owner

Indoco Remedies Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Apixaban 5 mg is commonly used to prevent and treat blood clots in various conditions. It is often prescribed for individuals at risk of deep vein thrombosis (DVT) or pulmonary embolism (PE). This medication is also used to reduce the risk of stroke in patients with atrial fibrillation. Understanding what is apixaban used for can help patients manage their health effectively.

Side Effects

Apixaban 5 mg may cause common side effects such as bleeding, bruising, and nausea. Some users may experience dizziness or stomach pain. It is important to monitor for any unusual symptoms and consult a healthcare provider if severe side effects occur.

Precautions & Warnings

Apixaban 5 mg should be handled with care to avoid bleeding risks. Patients should inform their healthcare provider about any other medications they are taking, especially those that affect blood clotting. Regular monitoring may be necessary to ensure the medication is working as intended.

Avoid Interactions

Apixaban 5 mg can interact with other medications, including blood thinners, NSAIDs, and certain antibiotics. Alcohol consumption should be limited as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Apixaban is used to prevent and treat blood clots, reduce stroke risk in atrial fibrillation, and manage conditions like DVT and PE.

Apixaban is taken orally, typically once or twice daily as prescribed. Follow your healthcare provider's instructions for the best results.

Common side effects include bleeding, bruising, nausea, dizziness, and stomach pain. Severe side effects should be reported to a healthcare provider.

Apixaban can interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Precautions include monitoring for bleeding, avoiding alcohol, and informing your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.